Radiochemotherapy With Cetuximab, Cisplatin, and Amifostine for Locally Advanced Head and Neck Cancer: A Feasibility Study-Reference-Cited by-同舟云学术

Radiochemotherapy With Cetuximab, Cisplatin, and Amifostine for Locally Advanced Head and Neck Cancer: A Feasibility Study

Published:2010-05 Issue:1 Volume:77 Page:9-15
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Koukourakis Michael I.,Tsoutsou Pelagia G.,Karpouzis Antonios,Tsiarkatsi Maria,Karapantzos Ilias,Daniilidis Vassilios,Kouskoukis Constantinos

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Forastiere AA, Ang KK, Brizel DNY. Head and neck cancers. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, version 2.2008. http://www.nccn.org.

2. Multidisciplinary management of locally advanced SCCHN: Optimizing treatment outcomes;Ang;Oncologist,2008

3. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data;Pignon;Lancet,2000

4. Update of MACH-NC (meta-analysis of chemotherapy in head and neck cancer) database focused on concomitant chemoradiotherapy;Bourhis;J Clin Oncol,2004

5. for the Meta-Analysis of Radiotherapy in Carcinomas of Head and Neck (MARCH) Collaborative Group. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis;Bourhis;Lancet,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head–Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay;Current Oncology;2023-09-29

2. Effects of Tetrandrine on the Apoptosis of Cisplatin-resistant Oral Cancer Cells;Pharmacognosy Magazine;2023-04-01

3. A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer;Medical Oncology;2022-12-30

4. Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?;Anticancer Research;2021-01

5. ‘Stemness’ and ‘senescence’ related escape pathways are dose dependent in lung cancer cells surviving post irradiation;Life Sciences;2019-09